Evidence map›Paper›PMID 36890281›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2023

Nasotracheal enterococcal carriage and resistomes: detection of optrA-, poxtA- and cfrD-carrying strains in migratory birds, livestock, pets, and in-contact humans in Spain.

Idris Nasir Abdullahi, Carmen Lozano, Guillermo Juárez-Fernández, Ursula Höfle, Carmen Simón, Silvia Rueda, Angela Martínez, Sandra Álvarez-Martínez, Paula Eguizábal, Beatriz Martínez-Cámara and 2 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Cross-Sector Antimicrobial Resistance and Virulence inAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Genomic analysis ofFrontiers in microbiology · 2024
    Article
  9. Prevalence and genetic diversity ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Idris Nasir AbdullahiArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Carmen LozanoArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Guillermo Juárez-FernándezArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Ursula HöfleSpanish Wildlife Research Institute IREC (CSIC-UCLM-JCCM), SaBio (Health and Biotechnology) Research Group, Ciudad Real, Spain.
Carmen SimónFaculty of Veterinary Medicine, University of Zaragoza, Zaragoza, Spain.
Silvia RuedaArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Angela MartínezArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Sandra Álvarez-MartínezArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Paula EguizábalArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Beatriz Martínez-CámaraArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Myriam ZarazagaArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain.
Carmen TorresArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, Logroño, 26006, Spain. carmen.torres@unirioja.es.ORCID http://orcid.org/0000-0003-3709-1690
Universidad de La Rioja · ESInstituto de Investigación en Recursos Cinegéticos · ESUniversidad de Zaragoza · ES

Funding

European Union's H2020 research and innovation programme under the Marie Sklodowska-Curie grant 801586MCIN/ AEI /10.13039/501100011033 of Spain PID2019-106158RB-I00regional government of Castilla - La Mancha co-financed by the European Union's funds for regional development (Feder) SBPLY/19/180501/000325
6 · The paper itself

Abstract

This study determined the carriage rates and antimicrobial resistance (AMR) genes of enterococci from nasotracheal samples of three healthy animal species and in-contact humans. Nasal samples were collected from 27 dog-owning households (34 dogs, 41 humans) and 4 pig-farms (40 pigs, 10 pig-farmers), and they were processed for enterococci recovery (MALDI-TOF-MS identification). Also, a collection of 144 enterococci previously recovered of tracheal/nasal samples from 87 white stork nestlings were characterized. The AMR phenotypes were determined in all enterococci and AMR genes were studied by PCR/sequencing. MultiLocus-Sequence-Typing was performed for selected isolates. About 72.5% and 60% of the pigs and pig-farmers, and 29.4% and 4.9%, of healthy dogs and owners were enterococci nasal carriers, respectively. In storks, 43.5% of tracheal and 69.2% of nasal samples had enterococci carriages. Enterococci carrying multidrug-resistance phenotype was identified in 72.5%/40.0%/50.0%/23.5%/1.1% of pigs/pig-farmers/dogs/dogs' owners/storks, respectively. Of special relevance was the detection of linezolid-resistant enterococci (LRE) in (a) 33.3% of pigs (E. faecalis-carrying optrA and/or cfrD of ST59, ST330 or ST474 lineages; E. casseliflavus-carrying optrA and cfrD); (b) 10% of pig farmers (E. faecalis-ST330-carrying optrA); (c) 2.9% of dogs (E. faecalis-ST585-carrying optrA); and (d) 1.7% of storks (E. faecium-ST1736-carrying poxtA). The fexA gene was found in all optrA-positive E. faecalis and E. casseliflavus isolates, while fexB was detected in the poxtA-positive E. faecium isolate. The enterococci diversity and AMR rates from the four hosts reflect differences in antimicrobial selection pressure. The detection of LRE carrying acquired and transferable genes in all the hosts emphasizes the need to monitor LRE using a One-Health approach.

Indexed as

Anti-Infective AgentsEnterococcus faeciumGram-Positive Bacterial InfectionsAnimalsAnti-Bacterial AgentsBirdsDogsDrug Resistance, BacterialEnterococcusEnterococcus faecalisHumansLinezolidLivestockMicrobial Sensitivity TestsSpainSwineAnti-Bacterial AgentsAnti-Infective AgentsLinezolidAntimicrobial resistomescfrDLinezolid resistanceLivestockMigratory birdsNasal enterococcioptrAPetspoxtA

Identifiers

PMID36890281
PMCPMC10105672
OpenAlexW4323537474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.